- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Delivra Health Brands
Market Cap: CA$7.0m
Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.
DHB
CA$0.20
7D
5.3%
1Y
-55.6%
IM Cannabis
Market Cap: CA$7.0m
Engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
IMCC
CA$2.27
7D
3.2%
1Y
-60.2%
Palatin Technologies
Market Cap: US$5.0m
A biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States.
0KF3
US$0.15
7D
61.4%
1Y
-92.8%
Clearmind Medicine
Market Cap: US$5.0m
A clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.
CMND
US$0.99
7D
2.4%
1Y
-18.9%
Genflow Biosciences
Market Cap: UK£3.7m
Operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium.
GENF
UK£0.0095
7D
5.6%
1Y
-56.3%
Core One Labs
Market Cap: CA$6.8m
Operates as a psychedelic research and development company.
COOL
CA$0.14
7D
0%
1Y
-46.3%
Conduit Pharmaceuticals
Market Cap: US$4.9m
A clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility.
CDT
US$0.39
7D
-2.5%
1Y
-99.9%
Therma Bright
Market Cap: CA$6.8m
Acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace.
THRM
CA$0.015
7D
-25.0%
1Y
0%
Innovative Holdings Alliance
Market Cap: US$4.9m
A medical technology holding company, offers personal care products in North America.
IHAI
US$0.093
7D
-6.1%
1Y
-7.0%
Bionoid Pharma
Market Cap: US$4.9m
Engages in the hemp cultivation business.
BINP
US$0.11
7D
-15.4%
1Y
n/a
Sunshine Biopharma
Market Cap: US$4.8m
Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
SBFM
US$1.50
7D
20.0%
1Y
-91.9%
Eastgate Biotech
Market Cap: US$4.8m
A development stage company, develops novel formulations of natural compounds and pharmaceutical products.
ETBI
US$0.0045
7D
0%
1Y
n/a
TrivarX
Market Cap: AU$7.4m
A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.
TRI
AU$0.013
7D
-7.1%
1Y
-53.6%
SenesTech
Market Cap: US$4.8m
Engages in the development and commercialization of a technology for managing animal pest populations through fertility control.
SNES
US$2.81
7D
3.7%
1Y
-59.3%
Epsilon Healthcare
Market Cap: AU$7.2m
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada.
EPN
AU$0.024
7D
0%
1Y
20.0%
Invion
Market Cap: AU$7.4m
A clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia.
IVX
AU$0.095
7D
-3.1%
1Y
-82.7%
dorsaVi
Market Cap: AU$7.3m
Engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States.
DVL
AU$0.01
7D
11.1%
1Y
-28.6%
Ecofibre
Market Cap: AU$7.3m
Engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia.
EOF
AU$0.02
7D
0%
1Y
-62.3%
Autonomix Medical
Market Cap: US$4.7m
A development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.
AMIX
US$1.95
7D
9.6%
1Y
-96.1%
Xenetic Biosciences
Market Cap: US$4.6m
A biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.
XBIO
US$2.91
7D
-4.9%
1Y
-19.3%
Valeo Pharma
Market Cap: US$4.6m
A specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceuticals and hospital specialty products for unmet medical needs in Canada.
VPHI.F
US$0.047
7D
0%
1Y
-59.4%
Zero Candida Technologies
Market Cap: CA$6.4m
A technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis.
ZCT
CA$0.33
7D
-2.9%
1Y
n/a
Virax Biolabs Group
Market Cap: US$4.6m
A biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology.
VRAX
US$1.08
7D
2.9%
1Y
28.6%
Sharps Technology
Market Cap: US$4.6m
A medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.
STSS
US$4.57
7D
-3.4%
1Y
-99.7%
Reflect Scientific
Market Cap: US$4.6m
Through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide.
RSCF
US$0.054
7D
39.8%
1Y
0.2%
Celadon Pharmaceuticals
Market Cap: UK£3.4m
Engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines.
CEL
UK£0.05
7D
11.1%
1Y
-94.9%
Quoin Pharmaceuticals
Market Cap: US$4.5m
A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
QNRX
US$7.70
7D
24.4%
1Y
-71.1%
PD-Rx Pharmaceuticals
Market Cap: US$4.5m
Engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States.
PDRX
US$2.75
7D
0%
1Y
n/a
Bakhu Holdings
Market Cap: US$4.5m
Produces, manufactures, and sells cannabis-related byproducts for medical, food additive, and recreational use.
BKUH
US$0.015
7D
0%
1Y
-87.7%
Alaunos Therapeutics
Market Cap: US$4.5m
A clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders.
TCRT
US$2.84
7D
-0.4%
1Y
-75.5%
WEED
Market Cap: US$4.5m
Focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia.
BUDZ
US$0.034
7D
1.7%
1Y
-56.4%
Invex Therapeutics
Market Cap: AU$7.0m
A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.
IXC
AU$0.093
7D
-6.1%
1Y
22.4%
NeuroScientific Biopharmaceuticals
Market Cap: AU$6.9m
Engages in the research and development of novel peptide-based pharmaceutical products.
NSB
AU$0.048
7D
-7.7%
1Y
4.3%
CanadaBis Capital
Market Cap: CA$6.2m
Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.
CANB
CA$0.05
7D
0%
1Y
-44.4%
Titan Pharmaceuticals
Market Cap: US$4.4m
Does not have significant operations.
TTNP
US$4.67
7D
-8.3%
1Y
-26.3%
Bounce Mobile Systems
Market Cap: US$4.4m
Delex Healthcare Group, Inc. engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.
BNCM
US$0.0074
7D
12.1%
1Y
n/a